TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 3 | -0 | 0 | 1 | 9 | 12 | 16 | 6 |
S | %wins | 33 | 67 | 67 | 33 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/4/19 18:07 | 8/30/19 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Patton Cynthia M | CA | O | SVP,CCO | S.d | -2,794 | 208.07 | 0 | -13 | -38 | 22 | D | ||||||||||||||
12/3/18 20:11 | 11/29/18 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Patton Cynthia M | CA | O | SVP,CCO | S.d | -361 | 202.88 | 0 | -2 | -8 | 22 | D | ||||||||||||||
5/24/17 19:35 | 5/24/17 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Patton Cynthia M | CA | O | SVP,CCO | S | -451 | 154.40 | 0 | -3 | -12 | 22 | D | ||||||||||||||
6/3/15 19:16 | 6/2/15 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Patton Cynthia M | CA | O | SVP,CCO | S | -711 | 157.06 | 33 | -5 | -21 | 17 | D | 62 | 37 | -4 | -1 | -7 | -1 | -5 | -1 | 1 | -1 | -1 | -3 | 4 | 3 |
8/7/14 16:20 | 8/5/14 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Patton Cynthia M | CA | O | SVP,CCO | S.d | -338 | 127.97 | 33 | -3 | -13 | 18 | D | 63 | 23 | 12 | 13 | 6 | 10 | 4 | 1 | 1 | 2 | 10 | 28 | 23 | 37 |
5/17/13 17:42 | 5/16/13 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Patton Cynthia M | CA | O | SVP,CCO | S.d | -372 | 105.01 | 33 | -4 | -19 | 16 | D | 81 | 52 | 24 | 24 | 1 | -3 | 1 | -1 | -3 | 0 | -6 | 1 | 8 | 8 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |